Loyal Valley Capital (LVC) is a private equity firm based in Shanghai, China, established in 2015. It specializes in growth investments in middle market companies, focusing on sectors that are poised for transformation in the Chinese market, particularly in consumer technology, healthcare, and advanced manufacturing. With over $1.6 billion in assets under management, LVC employs a rigorous research-driven investment process that combines top-down and bottom-up analysis to identify promising investment themes. The firm aims to act as a trusted shareholder, driving value creation and growth through strategic initiatives supported by a robust network of business leaders. LVC manages capital for a diverse group of international institutional investors, including sovereign wealth funds and family offices, as well as prominent entrepreneurs associated with China's Fortune 500 companies. The firm was founded by Andy Lin, who has a notable background in investment and entrepreneurship.
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
Zhishan Weixin Biotechnology
Series A in 2023
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
Jinyuansheng engages in the development, smelting, and deep processing of energy metal mineral resources, lithium-ion battery cathode precursor materials, and the recycling and echeloning of power batteries and materials. They use the power of science and technology to create new materials, support energy, and create a greener world for humans.
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area of respiratory viral infection and viral hepatitis, for global and China market. We strive to build a science-driven biopharmaceutical company that aims to be a leader in antiviral drug discovery and development. To achieve so, we aspire for the excellence of science and be innovative. We operate with a razor-sharp focus and aggressiveness with a timely and cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners.
Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.
Alit positioned as a supplier of instruments, equipment and technical services in the life science and biotechnology industries, the company has developed several series of products from Biotech, Altair, Rigel and Mira after launching its self-developed Countstar IC1000 cell analyzer in 2011.
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.
ABclonal Technology is a rapidly growing life science research and diagnostic reagents provider. With scientists from world-class universities, the company thrives on improving the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS library preparation kits and molecular enzymes.
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics，pesticides，veterinary drugs, and new cosmetics.
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
Leads Biolabs is a biotechnology company that develops treatment outcomes and access for patients worldwide. The company is committed to researching and developing novel antibody-based therapeutics in oncology and immunological disease areas in order to meet patients' global unmet needs. On the monoclonal antibody and bispecific antibody development technology platform, they already have a robust research and development pipeline with over ten innovative cancer immunotherapy antibody projects. Leads Biolabs was founded in 2014 and is headquartered in China.
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
EdiGene is dedicated to the development of genome editing technology for human health. Genome editing technology enables the targeted modification of genetic information in human cells, including gene knockout, knock-in and targeted mutations. They aim at providing the high quality products and services for the patients, the pharmaceutical industry, and the scientific research community with the most advanced genome editing technology.EdiGene innovates and applies genome editing technology to developing human therapeutic products. Their therapeutic approach is to treat diseases at the molecular level, making gene therapy safer and more effective.
Xiaoxian Dun is a healthy food products company that develops products from bird's nests. The company focuses on researching and developing a way to make a bowl of bird's nests that are just as good as a stew pot's slow-cooked bird's nest so that more people can enjoy it. The company seeks to revive and expand the conventional bird's nest market.
Arctic Vision is a China-based clinical-stage specialty ophthalmology company with a leading portfolio of breakthrough technologies. The Company's vision is to address ophthalmology's unmet needs through innovative therapies in China, Asia, and globally. Arctic Vision is established by top-tier life sciences investors and led by an elite team of ophthalmic industry veterans with substantial and compelling China and global experiences in R&D and commercialization of eye care products.
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.
Regor Therapeutics is a clinical-stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform, seamlessly integrating structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development. Regor has assembled a world-class scientific team and demonstrated high efficiency in producing best- and first-in-class molecules.
Zhishan Weixin Biotechnology
Series A in 2021
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
CARsgen is a leading clinical-stage immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has partnership with Shanghai Cancer Institute and Shanghai Renji Hospital. The company is leading the first tier of CAR-T development, by completing World’s first hepatocellular carcinoma (HCC) and China’s exclusive glioblastoma multiforme (GBM) dose ascending injection tests. Funded by leading venture capital firm BVCF, CARsgen is well-positioned to bring a novel cancer therapeutics to the market in China and worldwide.
Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.
Heyuan Biotechnology is a biotechnology company focusing on the field of gene therapy services. They offer gene therapy vectors, gene function research, drug targets, and efficacy for the basic research of gene therapy research, among other services.
Hygeia Healthcare Group is a leading oncology-focused healthcare group in China. The company operates its own hospitals, provides third-party radiotherapy service, and manages partner hospitals. Its core business consists of 7 oncology hospitals and 3 managed hospitals in in 6 provinces in China. In addition, the company provides services to 15 hospital partners (including managed hospitals) in 9 provinces of China on its radiotherapy centers.
Beaver Education is an Internet education company committed to providing professional and high-quality online teaching services for elementary and middle school families as well as educational institutions. The company's products mainly include online subject training courses and online personalized tutoring tools.
Mabwell Biotech is a Chinese innovative biopharmaceutical company based in Shanghai Zhangjiang Hi-Tech Park. Since its establishment in 2017, it has absorbed and newly established nine biopharmaceutical R&D and production enterprises. At present, the company focuses on the development and manufacturing of macromolecular drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins. There are more than thirty varieties of drugs at different stages of development covering tumor, autoimmunity, anti-infection and ophthalmic diseases. Among them, six of them have entered the clinical stage, and three of them are in Phase III clinical trials.
Pop Mart is a black-box doll retailer. Pop Mart engages in pop culture and entertainment industry. Pop Mart established a platform of integrated operations that covers the entire industry chain of designer toys.
Perfect Diary is an e-commerce-based cosmetic brand. The company is committed to exploring the trends in international cosmetics and the frontiers of fashion to provide easy-to-use cosmetics products for young Asian women.Perfect Diary is professional in branding and online traffic management. By launching co-branded cosmetic products with KOLs, idols and even some famous organizations like the British Museum
Abbisko Therapeutics is a drug company dedicated to innovative drug research and development. The company is founded by a group of seasoned drug hunters with rich research and managerial experience in top pharmaceutical companies globally and in China.
RemeGen, Ltd. ("RemeGen") is a biopharmaceutical company in China dedicated to fulfilling unmet medical needs for patients with life-threatening conditions. RemeGen's main focus is research and development, manufacturing and commercialization of novel biologics, most notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs). Headquartered in Yantai, Shandong Province, China, RemeGen has labs/offices in Beijing and California.
Kaishuo Jianggushi is a children's content provider. Also known as Kaishu Story, the brand is focusing on children’s stories with additional products such as audio series and online parenting courses.
Juvenile is a learning and counseling application for primary and secondary schools, mainly for 7-15 year olds. The application covers the knowledge points and exam focus of each subject in primary and secondary schools, and answers the test proposition in detail. The knowledge coverage can meet the needs of further studies, and can also help students to self-study after class. The app also provides students with effective learning method guidance, audio books and learning materials.
The company has built a global level of bio-pharmaceutical research and development and industrialization platform; established for cancer, autoimmune diseases, inflammation and cardiovascular disease of the rich product line. The scale of the company's platform, hardware and software facilities, the number of new drug product lines, R & D team in the country are the same industry-leading level. Kang Fang biological has been with the international and domestic listed pharmaceutical companies to establish a cooperative relationship, the joint development of innovative antibodies to new drugs, is a strategic cooperation in the form of development of new drugs in the forerunner.
Happy Twist, the largest drama agency in China, was founded in 2003 and has created a large amount of popular dramas, including “Clown Loves Beauty”, “Count of Mountain Wulong”, “Dream of those Years”, etc. In Oct 2015, Happy Twist’s first movie, “Xialuo’s trouble” earned nearly 1.5 billion RMB box office with 20 million RMB production cost. In Oct 2016, its second movie, “Donkey water” came into existence and achieved a high reputation. With more than 20 high quality original shows (IPs owned by the company), Happy Twist had over 1,600 tour shows across China in 2016.
Allist Pharmaceuticals is a pharmaceutical enterprise that discovers, develops, and commercializes innovative medicines. Allist Pharmaceuticals is oriented by unmet clinical demands in the global pharmaceutical market, with a special focus on tumor treatment, under the development concept of advancing long life through scientific and technological innovation. Allist Pharmaceuticals develops medicines with the commitment to creating safe, effective, and inclusive innovative drugs with independent intellectual property rights.
NetEase Cloud Music operates an online music platform and offers streaming services. It also develops music applications for smartphones. William Lei Ding founded NetEase Cloud in 2013, with its headquarters in Beijing in China. NetEase Cloud Music operates as a subsidiary of NetEase.
Juvenile is a learning and counseling application for primary and secondary schools, mainly for 7-15 year olds. The application covers the knowledge points and exam focus of each subject in primary and secondary schools, and answers the test proposition in detail. The knowledge coverage can meet the needs of further studies, and can also help students to self-study after class. The app also provides students with effective learning method guidance, audio books and learning materials.
Infinovo was formed in 2016. For the past several years, Infinovo has been focusing on developing an accurate and affordable CGM (Continuous Glucose Monitoring) for patients which will be available for both Type 1 and Type 2 Diabeties. The company has developed a CGM which can compete in the global market for accuracy, durability, and design.
EVE Energy was established in 2001 and became listed on Shenzhen GEM in 2009 as the first listed enterprise with lithium battery for principle work (stock code: 300014). As a national high-tech enterprise, EVE focuses on lithium battery innovation and manufacturing. After 33 years’ accumulation and 15 years’ endeavor, EVE now stands in the leading position of national lithium primary battery and takes front position worldwide in lithium thionyl chloride battery manufacture.
Abbisko Therapeutics is a drug company dedicated to innovative drug research and development. The company is founded by a group of seasoned drug hunters with rich research and managerial experience in top pharmaceutical companies globally and in China.
Wajijia Entertainment provides network and entertainment production services. Their businesses include producing television content and music videos that enable consumers to enjoy a variety of entertainment content and music.
Jinfuzi.com (金斧子) is on-line investment platform that allows users to invest in a variety of financial products (PE/VC, Trust, foreign funds etc.) via Internet. It aims to help the investor to select the investment portfolio that suits his return-risk preference. There are two main products/ mobile apps: Finance Port -金融港 and Snowball -滚雪球.
InnoCare Pharma is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for cancer and autoimmune diseases. Headquartered in Beijing, China, with additional offices in major cities, the company is advancing a robust product pipeline that includes Orelabrutinib, a Bruton’s tyrosine kinase inhibitor, which is in various stages of clinical trials for conditions such as chronic lymphocytic leukemia and mantle cell lymphoma. InnoCare is also developing ICP-192, a pan-inhibitor of fibroblast growth factor receptor, and ICP-105, a FGFR4 inhibitor aimed at treating advanced hepatocellular carcinoma. In addition, the company has a range of preclinical stage products targeting neurotrophic tyrosine receptor kinase fusion-positive cancers and T-cell mediated autoimmune disorders. Founded in 2015, InnoCare is committed to pushing the boundaries of medical innovation and improving patient outcomes.
Immupeutics Medical Technology Co., Ltd. is a biomedical research technology company dedicated to the development and application of tumor immunotherapy technology. The company mainly involves the research and application of immunotherapy for many different types of tumors.
ByteDance creates and operates various content platforms, including TikTok and Douyin, enabling users to connect, create, and consume content. The company focuses on enriching lives through innovative technology and has expanded its offerings to include tools for content creation and collaboration.
Linklogis is a supply chain financing service provider committed to developing a supply chain financial business based on practical scenes, the Internet, and statistics, holding the banner of building China's largest Financial Services Company with a specialized supply chain and increasing shareholder value.
WeShare is a Chinese financial services provider. The company is helping consumer financial institutions to enhance their ability to access customers, risk control and funds.
Teligene was established in 2011. It is a high-tech pharmaceutical research and development company focusing on the research and development and industrialization of small molecule innovative drugs. The company's senior technical management team is experienced and familiar with cutting-edge drug development technologies and development trends at home and abroad. The company mainly aims to research and develop hot spots and develop trends of new international small molecule targeted anti-tumor drugs, and designs, screens, optimizes and develops original small molecule targeted anti-tumor drugs with independent intellectual property rights.
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology. The company is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, formed in 2009. It is headquartered in the Shanghai Caohejing High-Technology Park.
Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.
Innomed medical niche markets' products and services. They continue to provide consumers with helpful advice and assistance in their department so that they can carry out their care as as possible. For global medical startup firms, they complete late-stage commercialization partners.
Kaishuo Jianggushi is a children's content provider. Also known as Kaishu Story, the brand is focusing on children’s stories with additional products such as audio series and online parenting courses.
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi-hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation.
Genecast offers DNA testing of tumors and gene-based medicine guidance. The company claims expertise in lung, colon, liver and breast cancers. Genecast plans to use the proceeds for further research and clinical trials, as well as expanding distribution channels.
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.
Sugarman Media
Series A in 2017
Established in October 2013, Sugarman Media is a comprehensive film and television organization integrating film and television planning, production and distribution, post-production, entertainment marketing, and performing arts brokerage. The company's main business is the production of online dramas, and has produced two explosive works "The Hurry" and "The Best of Us". The company has the ability to continue to produce high-quality content, and will be committed to creating high-quality film and television IP through a series of plays in the future.
Fortune Finance
Venture Round in 2017
Leading financial and insurance technology company in China
Fengjia Microelectronics (Shanghai) Co., Ltd. is a chip design company that provides world-class mixed-signal integrated circuits and system-on-chips. Fengjia Microelectronics is committed to developing low-power system-on-chips for Internet of Things (IoT) smart terminals. Our low-power Bluetooth solutions offer the lowest power consumption, highest integration and the best price/performance ratio.
The Child Academy provides a developmentally appropriate learning environment where all children's emotional, social, physical, and intellectual needs are satisfied in a supportive, artistic environment. They employ a combination of play-based and literacy activities to build self-esteem, critical thinking, problem solving, and management skills in an atmosphere that incorporates scheduled, routine, and open discovery activities.
Gaosi Education Group is a Chinese educational and training institution. It is a domestic extracurricular tutorial institution that provides services for middle and primary schools. Gaosi Education Group offers courses for gifted children from primary school to junior high school. It has set up personalized one-to-one teaching centers, where mathematics competitions for primary, secondary, and high schools are one of the featured courses. Gaosi currently has nearly 10,000 students and 100 full-time teachers and personnel of teaching and researching teams. The institution was founded in December 2009 and is headquartered in Gaosi Education Building, Wudaokou, Haidian District, Beijing.
Linklogis is a supply chain financing service provider committed to developing a supply chain financial business based on practical scenes, the Internet, and statistics, holding the banner of building China's largest Financial Services Company with a specialized supply chain and increasing shareholder value.
Pipilu is a provider of entertainment content and products intended for children.
Studio9
Series A in 2017
Established in 2013, Studio 9 is a leading original animation IP creation company. It has the highest-yield production line of comics and 2D & 3D animation in China. The company has built its IP production committee to further expand the value of its IP in animation, movies and games. It has also successfully created China's first action animation IP " The Outcast ", and hot IPs such as “No”, “Heaven to Earth”, etc.
Avary Holding is a joint-stock firm that is involved in printed circuit board design, research, development, manufacturing, and sales. The primary products of the company are communication boards, boards for computers and consumer electronics, and other boards. Additionally, these goods are primarily used in downstream goods including mobile phones, network equipment, tablets, wearable tech, notebook computers, servers, storage, automotive electronics, and others. Both domestically and internationally, the company distributes its goods.
Haixue is an internet education company. They engage in using teachers, teaching research, and teaching service systems to systematically enhance the workplace value of groups. The company uses live lectures and high-definition large screens to incorporate live broadcasting into the training system. HiLearn creates personalized learning files and repeatedly recommends challenging knowledge points for students through the use of artificial intelligence technology combined with big data analysis. and other networks for online learning.
ECNUAS is a global private boarding institution that caters to students from kindergarten through high school. The primary objective of the school is to establish a Chinese educational model that has a significant impact on the world. It combines the finest elements of both Eastern and Western educational philosophies and methodologies, while also identifying and leveraging high-quality educational resources at local, national, and international levels.
iDreamsky is a Shenzhen, China based company founded in 2009. Even since it has established to be one of the leading smartphone application developers in China. With major clients such as Lenovo, China Telecom, Chung Hwa Telecom, HTC and many more. At 2011, iDreamsky have successfully secure a 2 million USD seed investment from Hwa Xiu Investment Group to create a new business operation: Skynet a one stop solution for game developer to expand and establish their business in China.
Xinshixiang is a well-known brand in the content field which has extended from textual content manufacturing to famous events. The company's platform provides contents including personalized recommendation, emotional companionship, value puzzlement solutions, enabling the young generation to achieve self-worth through reading.
Shanghai Junshi Biosciences is involved in the development and production of therapeutic medicines. They provides tumor immunotherapy, for autoimmune diseases, and chronic metabolic diseases. , Nervous system diseases, infectious diseases, and other treatments.
China Mercy Health Group was initiated and established by Liu Xiaocheng of TEDA International Cardiovascular Hospital. Dean Liu Xiaocheng has served as the vice president, principal and party committee secretary of the Chinese Academy of Medical Sciences and China Union Medical University. In 2001, Dean Liu went to Tianjin Development Zone to prepare to build TEDA International Cardiovascular Hospital. TEDA International Cardiovascular Hospital is now included in the Grade A Class A Cardiovascular Specialized Hospital and Institute of Cardiovascular Research of the Management System of Peking Union Medical College of Chinese Academy of Medical Sciences , Is the Tianjin Medical University School of Cardiovascular Diseases, National Coronary Heart Disease and Arrhythmia Intervention Diagnosis and Training Training Base.
Sound Solutions
Private Equity Round in 2016
Sound Solutions, a subsidiary of [Dover Corporation](/organization/dover)'s Knowles Electronics and formerly owned by [NXP](/organization/nxp), manufactures speakers and receivers for cell phones and other electronic devices.
Linklogis is a supply chain financing service provider committed to developing a supply chain financial business based on practical scenes, the Internet, and statistics, holding the banner of building China's largest Financial Services Company with a specialized supply chain and increasing shareholder value.
Kangning Hospital is a mental health center that provides medical care for patients with mental disorders. They offer forensics, womens psychiatry, addictive behavior, geriatric psychiatry, mental health services, a depression clinic, a sleep clinic, a child and adolescent psychology center, and teleconsultation.
Bilibili provides high-quality content and an immersive entertainment experience, and have built their platform based on the strong emotional connections of their users to their content and communities. They started as a content community inspired by ACG, and have evolved into a full-spectrum online entertainment world covering a wide array of genres and media formats, including videos, live broadcasting, and mobile games. They have a young and culturally aspirational user base willing to invest in a high-quality entertainment experience. Bilibili uses an Adobe Flash or HTML5 player, which can be manually switched, to play user-submitted videos hosted by either itself or third-party sources, while featuring a real-time overlaying subtitle system for interactive playback experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.